BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 26897743)

  • 1. Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?
    Kanzaki Y; Yuki M; Yamamura KI; Narumi Y; Ishizaka N
    Heart Vessels; 2016 Dec; 31(12):1950-1959. PubMed ID: 26897743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T1 and T2 mapping for early diagnosis of dilated non-ischaemic cardiomyopathy in middle-aged patients and differentiation from normal physiological adaptation.
    Mordi I; Carrick D; Bezerra H; Tzemos N
    Eur Heart J Cardiovasc Imaging; 2016 Jul; 17(7):797-803. PubMed ID: 26358692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of myocardial iron deficiency in nonischemic heart failure by cardiac T2* magnetic resonance imaging.
    Nagao M; Matsuo Y; Kamitani T; Yonezawa M; Yamasaki Y; Kawanami S; Abe K; Mukai Y; Higo T; Yabuuchi H; Takemura A; Yoshiura T; Sunagawa K; Honda H
    Am J Cardiol; 2014 Mar; 113(6):1024-30. PubMed ID: 24461766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of late gadolinium enhancement quantification in cardiac magnetic resonance imaging of hypertrophic cardiomyopathy with systolic dysfunction.
    Funada A; Kanzaki H; Noguchi T; Morita Y; Sugano Y; Ohara T; Hasegawa T; Hashimura H; Ishibashi-Ueda H; Kitakaze M; Yasuda S; Ogawa H; Anzai T
    Heart Vessels; 2016 May; 31(5):758-70. PubMed ID: 25820658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of left and right ventricular ejection and filling parameters of the heart using cine-MRI with breath holding technique. Clinical study of 42 patients with cardiomyopathy and coronary heart disease].
    Rominger MB; Bachmann GF; Geuer M; Puzik M; Ricken WW; Rau WS
    Rofo; 1999 Jun; 170(6):534-41. PubMed ID: 10420902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of adverse cardiac events in dilated cardiomyopathy using cardiac T2* MRI and MIBG scintigraphy.
    Nagao M; Baba S; Yonezawa M; Yamasaki Y; Kamitani T; Isoda T; Kawanami S; Maruoka Y; Kitamura Y; Abe K; Higo T; Sunagawa K; Honda H
    Int J Cardiovasc Imaging; 2015 Feb; 31(2):399-407. PubMed ID: 25348658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects.
    Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH
    Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients.
    Bayraktaroğlu S; Aydinok Y; Yildiz D; Uluer H; Savaş R; Alper H
    Diagn Interv Radiol; 2011 Dec; 17(4):346-51. PubMed ID: 21647857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hypertrophic non-obstructive cardiomyopathy assessed by dipyridamole thallium single photon emission computed tomography: comparisons with hypertrophic cardiomyopathy with a dilated heart].
    Mori T; Suda K; Ohnishi M; Kanoh Y; Shiotani H; Yokota Y; Fujitani K; Fukuzaki H; Maeda K
    J Cardiol; 1987 Mar; 17(1):35-46. PubMed ID: 3501444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of basal-septal fibrosis with LV outflow tract obstruction in hypertrophic cardiomyopathy: insights from cardiac magnetic resonance analysis.
    Nakamura T; Iwanaga Y; Yasuda M; Kawamura T; Miyaji Y; Morooka H; Miyazaki S
    Int J Cardiovasc Imaging; 2016 Apr; 32(4):613-20. PubMed ID: 26589516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of magnetic resonance imaging estimation of myocardial iron to left ventricular systolic and diastolic function in thalassemia.
    Leonardi B; Margossian R; Colan SD; Powell AJ
    JACC Cardiovasc Imaging; 2008 Sep; 1(5):572-8. PubMed ID: 19356483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.
    Inati A; Musallam KM; Wood JC; Sheikh-Taha M; Daou L; Taher AT
    Eur J Haematol; 2009 Dec; 83(6):565-71. PubMed ID: 19737308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of Cardiac Magnetic Resonance Fractal Analysis Combined With Myocardial Strain in Discriminating Isolated Left Ventricular Noncompaction and Dilated Cardiomyopathy.
    Zheng T; Ma X; Li S; Ueda T; Wang Z; Lu A; Zhou W; Zou H; Zhao L; Gong L
    J Magn Reson Imaging; 2019 Jul; 50(1):153-163. PubMed ID: 30565346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quantification of left and right ventricular systolic function in patients with dilated cardiomyopathy using real-time three-dimensional echocardiography].
    Tong K; Zhang J; Wang J; Zhou X; Lei X; Xu Y; Zhi G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 37(6):561-6. PubMed ID: 22772405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of postcontrast myocardial T1 value and delayed enhancement to reduced cardiac function and serious arrhythmia in dilated cardiomyopathy with left ventricular ejection fraction less than 35.
    Tachi M; Amano Y; Inui K; Takeda M; Yamada F; Asai K; Kumita S
    Acta Radiol; 2016 Apr; 57(4):430-6. PubMed ID: 25900838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of three-dimensional speckle-tracking imaging in detecting left ventricular systolic function in patients with dilated cardiomyopathy.
    He J; Yang L
    Echocardiography; 2019 Aug; 36(8):1492-1495. PubMed ID: 31268561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular magnetic resonance T2* mapping for the assessment of cardiovascular events in hypertrophic cardiomyopathy.
    Gastl M; Gruner C; Labucay K; Gotschy A; Von Spiczak J; Polacin M; Boenner F; Kelm M; Ruschitzka F; Alkadhi H; Kozerke S; Manka R
    Open Heart; 2020; 7(1):e001152. PubMed ID: 32201584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial intelligence study on left ventricular function among normal individuals, hypertrophic cardiomyopathy and dilated cardiomyopathy patients using 1.5T cardiac cine MR images obtained by SSFP sequence.
    Guo J; Lu H; Chen Y; Zeng M; Jin H
    Br J Radiol; 2022 May; 95(1133):20201060. PubMed ID: 35084208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.